Part of developing therapeutics is the need to identify patients who will respond to treatment. For HER2-targeted therapies, such as trastuzumab, the expression level of HER2 is used to identify ...
Several studies highlight utility of Ionpath’s multiplexed ion beam imaging (MIBI) technology in spatial proteomics applications MENLO PARK, Calif.--(BUSINESS WIRE)--Ionpath, a pioneer in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback